InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Monday, 08/26/2019 1:10:34 PM

Monday, August 26, 2019 1:10:34 PM

Post# of 232
News: $MDCO The Medicines Company Announces Positive Topline Results from First Pivotal Phase 3 Trial of Inclisiran

­ ORION-11 study met all primary and secondary efficacy endpoints with efficacy consistent with Phase 1 and 2 studies ­ Safety profile of inclisiran was at least as favorable as in ORION-1 Phase 2 and ORION-3 open-label extension studies ­ Detailed data will be presented...

In case you are interested The Medicines Company Announces Positive Topline Results from First Pivotal Phase 3 Trial of Inclisiran